144 related articles for article (PubMed ID: 28715026)
21. ENDOR investigation of the liganding environment of mixed-spin ferric cytochrome c'.
Usov OM; Choi PS; Shapleigh JP; Scholes CP
J Am Chem Soc; 2005 Jul; 127(26):9485-94. PubMed ID: 15984875
[TBL] [Abstract][Full Text] [Related]
22. NMR studies of the paramagnetic complex Fe(II)-bleomycin.
Lehmann TE; Ming LJ; Rosen ME; Que L
Biochemistry; 1997 Mar; 36(10):2807-16. PubMed ID: 9062108
[TBL] [Abstract][Full Text] [Related]
23. Effect of substrate on the diiron(III) site in stearoyl acyl carrier protein delta 9-desaturase as disclosed by cryoreduction electron paramagnetic resonance/electron nuclear double resonance spectroscopy.
Davydov R; Behrouzian B; Smoukov S; Stubbe J; Hoffman BM; Shanklin J
Biochemistry; 2005 Feb; 44(4):1309-15. PubMed ID: 15667224
[TBL] [Abstract][Full Text] [Related]
24. Geometries and electronic structures of cyanide adducts of the non-heme iron active site of superoxide reductases: vibrational and ENDOR studies.
Clay MD; Yang TC; Jenney FE; Kung IY; Cosper CA; Krishnan R; Kurtz DM; Adams MW; Hoffman BM; Johnson MK
Biochemistry; 2006 Jan; 45(2):427-38. PubMed ID: 16401073
[TBL] [Abstract][Full Text] [Related]
25. End-on and side-on peroxo derivatives of non-heme iron complexes with pentadentate ligands: models for putative intermediates in biological iron/dioxygen chemistry.
Roelfes G; Vrajmasu V; Chen K; Ho RY; Rohde JU; Zondervan C; La Crois RM; Schudde EP; Lutz M; Spek AL; Hage R; Feringa BL; Münck E; Que L
Inorg Chem; 2003 Apr; 42(8):2639-53. PubMed ID: 12691572
[TBL] [Abstract][Full Text] [Related]
26. Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA.
Burger RM; Peisach J; Horwitz SB
J Biol Chem; 1981 Nov; 256(22):11636-44. PubMed ID: 6170635
[TBL] [Abstract][Full Text] [Related]
27. On the mechanism of lipoxygenase-like action of bleomycin-iron complexes.
Kikuchi H; Tetsuka T
J Antibiot (Tokyo); 1992 Apr; 45(4):548-55. PubMed ID: 1375591
[TBL] [Abstract][Full Text] [Related]
28. Reaction of DNA-bound ferrous bleomycin with dioxygen: activation versus stabilization of dioxygen.
Fulmer P; Petering DH
Biochemistry; 1994 May; 33(17):5319-27. PubMed ID: 7513558
[TBL] [Abstract][Full Text] [Related]
29. EPR spectroscopic investigation of the lability of oxygen in activated bleomycin: implications for the mechanism of bleomycin-mediated DNA degradation.
Sam JW; Peisach J
Biochemistry; 1993 Feb; 32(6):1488-91. PubMed ID: 7679285
[TBL] [Abstract][Full Text] [Related]
30. Direct detection of a hydrogen ligand in the [NiFe] center of the regulatory H2-sensing hydrogenase from Ralstonia eutropha in its reduced state by HYSCORE and ENDOR spectroscopy.
Brecht M; van Gastel M; Buhrke T; Friedrich B; Lubitz W
J Am Chem Soc; 2003 Oct; 125(43):13075-83. PubMed ID: 14570480
[TBL] [Abstract][Full Text] [Related]
31. Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing Studies.
Davydov R; Strushkevich N; Smil D; Yantsevich A; Gilep A; Usanov S; Hoffman BM
Biochemistry; 2015 Dec; 54(48):7089-97. PubMed ID: 26603348
[TBL] [Abstract][Full Text] [Related]
32. Mössbauer study of iron bleomycin and its activation intermediates.
Burger RM; Kent TA; Horwitz SB; Münck E; Peisach J
J Biol Chem; 1983 Feb; 258(3):1559-64. PubMed ID: 6185486
[TBL] [Abstract][Full Text] [Related]
33. Role of the Proximal Cysteine Hydrogen Bonding Interaction in Cytochrome P450 2B4 Studied by Cryoreduction, Electron Paramagnetic Resonance, and Electron-Nuclear Double Resonance Spectroscopy.
Davydov R; Im S; Shanmugam M; Gunderson WA; Pearl NM; Hoffman BM; Waskell L
Biochemistry; 2016 Feb; 55(6):869-83. PubMed ID: 26750753
[TBL] [Abstract][Full Text] [Related]
34. Characterization of an Fe III-OOH species and its decomposition product in a bleomycin model system.
Bukowski MR; Zhu S; Koehntop KD; Brennessel WW; Que L
J Biol Inorg Chem; 2004 Jan; 9(1):39-48. PubMed ID: 14564557
[TBL] [Abstract][Full Text] [Related]
35. Pulsed ELDOR spectroscopy of the Mo(V)/Fe(III) state of sulfite oxidase prepared by one-electron reduction with Ti(III) citrate.
Codd R; Astashkin AV; Pacheco A; Raitsimring AM; Enemark JH
J Biol Inorg Chem; 2002 Mar; 7(3):338-50. PubMed ID: 11935358
[TBL] [Abstract][Full Text] [Related]
36. On the chemistry of RNA degradation by Fe.bleomycin.
Holmes CE; Duff RJ; van der Marel GA; van Boom J; Hecht SM
Bioorg Med Chem; 1997 Jun; 5(6):1235-48. PubMed ID: 9222517
[TBL] [Abstract][Full Text] [Related]
37. Ascorbate both activates and inactivates bleomycin by free radical generation.
Buettner GR; Moseley PL
Biochemistry; 1992 Oct; 31(40):9784-8. PubMed ID: 1382593
[TBL] [Abstract][Full Text] [Related]
38. Activation of bleomycin-Fe(III) by bleomycin-Cu(II) and cysteine.
Takahashi K; Takita T; Umezawa H
J Antibiot (Tokyo); 1987 Apr; 40(4):542-6. PubMed ID: 2438263
[TBL] [Abstract][Full Text] [Related]
39. Copper(I) . bleomycin. A structurally unique oxidation-reduction active complex.
Oppenheimer NJ; Chang C; Rodriguez LO; Hecht SM
J Biol Chem; 1981 Feb; 256(4):1514-7. PubMed ID: 6161924
[TBL] [Abstract][Full Text] [Related]
40. Redox active iron nitrosyl units in proton reduction electrocatalysis.
Hsieh CH; Ding S; Erdem ÖF; Crouthers DJ; Liu T; McCrory CC; Lubitz W; Popescu CV; Reibenspies JH; Hall MB; Darensbourg MY
Nat Commun; 2014 May; 5():3684. PubMed ID: 24785411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
